|
** MEDIA ALERT **
** MEDIA ALERT ** ** MEDIA ALERT **
AIDS
RESEARCH ALLIANCE FIRST IN LA
TO BEGIN HIV VACCINE STUDY
HIV vaccine study volunteer was injected on
Thursday, March 25, 2004
(Photos
below)
WEST
HOLLYWOOD, March 24th, 2004: AIDS ReSearch Alliance (ARA)
was the first research facility in Los Angeles to begin a
new, Phase I study of an experimental, preventative HIV/AIDS
vaccine. Thursday morning, at approximately 10:30 a.m., the
first vaccine volunteer, Herminio Reyes, was injected. Reyes
also agreed to speak to the press about his reasons for joining
the study.
There
was major media turnout as television stations KNBC-4, KABC-7,
KCBS-2, KCAL-9 and news radio station KFWB gathered to record
this significant event. Dr. Stephen J. Brown and Irl S. Barefield
represented AIDS ReSearch Alliance at the study kick-off.
This
vaccine, manufactured by Merck Co., Inc., has scientific potential
because it may stimulate production of antibodies to HIV proteins
and also elicit cellular immunity. The study is scheduled
to last five years and additional study volunteers are urgently
needed.
For
more information about this developing story, contact Michelle
Simek at 310.738.9726.
For information about joining the study, please contact the
AIDS ReSearch Alliance clinic at 310.358-2429.
To read more about the ARA/Merck Vaccine Trial, click
here. For more information about AIDS ReSearch Alliances
ongoing clinical trials, please click
here. To read about ARAs other groundbreaking research,
click here.
Photographs
by Neil S. Gordon
Local
television stations,
including KNBC-4, KCBS-2,
KABC-7, KCAL-9 and news
radio station KFWB
interview ARAs Medical Director
Dr. Stephen Brown.
|
Vaccine
study volunteer Herminio Reyes looks on as ARAs
Dr. Stephen Brown fields questions from the press.
|
A
prepared injection of the experimental HIV vaccine,
manufactured by
Merck & Co., Inc.
|
Dr.
Brown injects Herminio,
the first Los Angeles area
volunteer for the experimental
Merck HIV/AIDS vaccine study.
|
Dr.
Brown briefs reporters from
KNBC-4 and KFWB
on the currently enrolling
vaccine trial.
|
Herminio
Reyes, after receiving
his initial vaccination.
|
To
Top | ARA Home
|